FDA product code · Neurology
Stimulator, Electrical, Implanted, For Parkinsonian Symptoms
1 FDA decision since 2002. No recall names this code.
Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic Activa Parkinson's Control Therapy is indicated for adjunctive therapy in reducing some of the symptoms of advanced, levodopa-responsive Parkinsons disease that are not adequately controlled with medication.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of NHL at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · NHL
10in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NHL
Too few NHL 510(k)s in any year since 2007 to give a median.
Recalls per year · NHL
No recall names NHL since 2007.
Adverse event reports per year · NHL
197in 2025
MAUDE reports naming product code NHL, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 1 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 1 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 3 |
| 2018 | 6 | — | 0 | 66 |
| 2019 | 17 | — | 0 | 74 |
| 2020 | 11 | — | 0 | 146 |
| 2021 | 8 | — | 0 | 205 |
| 2022 | 6 | — | 0 | 214 |
| 2023 | 12 | — | 0 | 411 |
| 2024 | 14 | — | 0 | 396 |
| 2025 | 10 | — | 0 | 197 |
| 2026 | 10 | — | 0 | — |
Planning a device in NHL? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report